Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026)
Travere Therapeutics (TVTX) posted Prepaid Assets of $34.3 million for Q1 2026, up 19.43% on a QoQ basis from $28.8 million in Q4 2025, and up 152.25% year-over-year from $13.6 million in Q1 2025.
Travere Therapeutics (TVTX) Prepaid Assets (2013 - 2026) Analysis & Trends
Travere Therapeutics' Prepaid Assets history runs 14 years deep, the most recent figure standing at $34.3 million for Q1 2026.
- Quarterly Prepaid Assets rose 152.25% year-over-year to $34.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.3 million (up 152.25% YoY) and the FY2025 annual result came in at $28.8 million, up 126.72% from the prior year.
- Prepaid Assets was $34.3 million for Q1 2026 at Travere Therapeutics, up from $28.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $34.3 million in Q1 2026 and bottomed at $6.5 million in Q1 2022.
- A 5-year average of $16.2 million and a median of $13.6 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 34.39% — and 2026, when it jumped 152.25%.
- Travere Therapeutics' Prepaid Assets stood at $12.0 million in 2022, then soared by 60.68% to $19.3 million in 2023, then sank by 34.39% to $12.7 million in 2024, then surged by 126.72% to $28.8 million in 2025, then increased by 19.43% to $34.3 million in 2026.
- Business Quant data shows TVTX's Prepaid Assets at $34.3 million in Q1 2026, $28.8 million in Q4 2025, and $28.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.35 Mn |
| Dec 31, 2025 | 28.76 Mn |
| Sep 30, 2025 | 28.05 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 13.62 Mn |
| Dec 31, 2024 | 12.69 Mn |
| Sep 30, 2024 | 15.78 Mn |
| Jun 30, 2024 | 13.14 Mn |
| Mar 31, 2024 | 12.77 Mn |
| Dec 31, 2023 | 19.34 Mn |
| Sep 30, 2023 | 16.24 Mn |
| Jun 30, 2023 | 11.56 Mn |
| Mar 31, 2023 | 15.14 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Sep 30, 2022 | 8.55 Mn |
| Jun 30, 2022 | 9.28 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | 6.72 Mn |
| Sep 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 7.34 Mn |